Qin, Yidi
Kernan, Kate F.
Fan, Zhenjiang
Park, Hyun-Jung
Kim, Soyeon
Canna, Scott W.
Kellum, John A.
Berg, Robert A.
Wessel, David
Pollack, Murray M.
Meert, Kathleen
Hall, Mark
Newth, Christopher
Lin, John C.
Doctor, Allan
Shanley, Tom
Cornell, Tim
Harrison, Rick E.
Zuppa, Athena F.
Banks, Russell
Reeder, Ron W.
Holubkov, Richard
Notterman, Daniel A.
Michael Dean, J.
Carcillo, Joseph A.
Article History
Received: 16 December 2021
Accepted: 3 April 2022
First Online: 7 May 2022
Declarations
:
: The study was approved by the Institutional Review Board at University of Utah Central IRB # 70976.
: Not applicable.
: The authors have no competing interest but did have the following and sources of funding. Drs. Carcillo’s, Berg’s, Wessel’s, Pollack’s, Meert’s, Hall’s, Doctor’s, Cornell’s, Harrison’s, Zuppa’s, Reeder’s, Banks’s, and Holubkov’s institutions received funding from the National Institutes of Health (NIH). Drs. Carcillo’s, Newth’s, Shanley’s, and Dean’s institutions received funding from the National Institutes of Child Health and Human Development. Drs. Carcillo, Berg, Wessel, Polack, Meert, Hall, Newth, Doctor, Shanley, Cornell, Harrison, Zuppa, Reeder, Banks, Holubkov, Notterman, and Dean received support for article research from the NIH. Dr. Carcillo’s institution also received funding from the National Institutes of General Medical Sciences. Dr. Pollack disclosed that his research is supported by philanthropy from Mallinckrodt Pharmaceuticals. Dr. Hall received funding from Bristol Myers-Squibb (for service on an advisory board) and LaJolla Pharmaceuticals (service as a consultant), both unrelated to the current submission. Dr. Newth received funding from Philips Research North America. Dr. Doctor’s institution received funding from the Department of Defense and Kalocyte. Dr. Shanley received funding from Springer publishing, International Pediatric Research Foundation, and Pediatric Academic Societies. Dr. Cornell disclosed he is co-founder of Pre-Dixon Bio. Dr. Holubkov received funding from Pfizer (Data Safety Monitoring Board [DSMB] member), Medimmune (DSMB member), Physicians Committee for Responsible Medicine (biostatistical consulting), DURECT Corporation (biostatistical consulting), Armaron Bio (DSMB past member), and St Jude Medical (DSMB past member). The remaining authors have disclosed that they do not have any potential competing interests.